Pictet Asset Management
BMY icon

Pictet Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Pictet Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117M Buy
2,026,687
+594,258
+41% +$34.1M 0.11% 197
2026
Q1 		$86.9M Sell
1,432,429
-73,242
-5% -$4.27M 0.09% 231
2025
Q4 		$81.2M Buy
1,505,671
+7,926
+0.5% +$381K 0.08% 246
2025
Q3 		$67.5M Buy
1,497,745
+93,301
+7% +$4.36M 0.07% 268
2025
Q2 		$65M Buy
1,404,444
+8,354
+0.6% +$410K 0.07% 272
2025
Q1 		$85.1M Buy
1,396,090
+100,200
+8% +$5.84M 0.09% 223
2024
Q4 		$73.3M Buy
1,295,890
+161,739
+14% +$9.04M 0.08% 246
2024
Q3 		$58.7M Buy
1,134,151
+41,799
+4% +$1.96M 0.06% 268
2024
Q2 		$45.4M Buy
1,092,352
+42,253
+4% +$1.89M 0.05% 301
2024
Q1 		$56.9M Sell
1,050,099
-54,303
-5% -$2.77M 0.06% 284
2023
Q4 		$56.7M Buy
1,104,402
+15,320
+1% +$804K 0.06% 280
2023
Q3 		$63.2M Buy
+1,089,082
New +$66.7M 0.08% 254

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pictet Asset Management's BMY Position: Q2 2026 in Review

Pictet Asset Management increased its Bristol-Myers Squibb (BMY) stake by 41% in Q2 2026, buying an estimated $34.1M and bringing the position to 2,026,687 shares worth $117M. The position accounts for 0.11% of the portfolio, ranked #197.

Pictet Asset Management first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Pictet Asset Management held 2,026,687 shares of Bristol-Myers Squibb worth $117M as of Q2 2026.
  • Pictet Asset Management bought 594,258 Bristol-Myers Squibb shares in Q2 2026, an estimated $34.1M.
  • Bristol-Myers Squibb made up 0.11% of Pictet Asset Management's portfolio in Q2 2026, its #197 holding.
  • Pictet Asset Management first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.